Hair consultation

The hair consultation covers hair-fall and pattern hair-thinning across male and female contexts, hair-restoration medical pathways, scalp conditions including dandruff and selected inflammatory scalp patterns, hair-shaft and hair-quality concerns, hair-loss in younger adults, post-partum hair-fall presentations, telogen effluvium contexts, and laser-hair-reduction enquiries across face and body zones. Each recommendation is case-calibrated; the framework deliberately avoids one-size-fits-all hair-pathway routing.

Pattern hair-thinning (androgenetic alopecia) is the most common chronic pattern in adult patients and follows a recognisable pattern across the scalp. Telogen effluvium, by contrast, is typically a temporary increased-shed pattern triggered by a recognisable stressor (illness, post-partum context, nutritional deficiency, medication change). Other patterns — alopecia areata, scarring alopecias, traction-related thinning, selected inflammatory presentations — each have their own assessment framework. The consultation differentiates the pattern as part of the assessment rather than treating "hair-fall" as a single undifferentiated concern.

Yes. Early-stage assessment is often the most useful — pathway response is generally better when initiated earlier in the trajectory rather than after substantial established loss. The framework welcomes early-stage consultations and does not require the patient to have already tried multiple over-the-counter or non-prescription pathways before seeking dermatology input.

Yes. Patients presenting with both hair-fall (scalp pathway) and laser-hair-reduction (body or face hair-reduction pathway) questions can have both addressed in the same consultation, with the visit-length calibrated for multi-concern complexity at the booking conversation. Each concern follows its own pathway calibration.

No. Both male-pattern and female-pattern hair-thinning are addressed within the same dermatology framework with the same calibrated assessment, the same evidence-based pathway range, and the same realistic-outcome framing. Sex-specific pattern characteristics inform the differential and the calibration but do not produce separate framework branches.

Hair examination is calibrated to the presenting concern. The framework typically includes scalp inspection across the relevant zones, hair-pull test where appropriate, scalp dermoscopy where the differential warrants it (calibrated dermoscopic patterns differentiate pattern hair-thinning from other patterns), assessment of hair-shaft characteristics, and selected scalp-quality assessment. The scalp analysis page covers the technical layer.

Yes, in selected cases. Trichoscopy — scalp dermoscopy — adds calibrated detail to the differential between pattern hair-thinning, alopecia areata, scarring alopecias, and selected inflammatory patterns. The framework uses trichoscopy where it changes the assessment rather than as a routine scripted step on every visit. The dermoscopy page covers the broader dermoscopy framework.

The hair-pull test is a calibrated clinical step where appropriate, helping to assess active shedding and selected pattern characteristics. It is performed gently and the result is interpreted in the context of the broader assessment rather than as a standalone diagnostic. Patients with concerns about active shedding can ask about the test at the consultation.

Family-history is a substantive part of the hair-fall assessment because pattern hair-thinning has a strong familial component. The framework asks about family pattern across both sides of the family where the patient has the information; it informs the trajectory expectations and the maintenance pathway recommendation. Patients without the information are not at a disadvantage; the pattern characteristics observed at examination provide much of the calibration.

For selected hair-fall presentations, blood-work request is appropriate — selected nutritional markers (iron-axis, vitamin D, B12), thyroid-axis where relevant, and selected hormonal-axis investigations where the picture suggests them. The framework requests blood-work where it changes the recommendation rather than as a routine scripted panel on every visit. Cost of laboratory work sits with the laboratory pathway the patient uses.

The dermatology pathway range covers calibrated topical and oral pharmacology as the foundation pathway in most pattern hair-thinning cases, with selected procedural touch-points where appropriate (calibrated mesotherapy-style scalp pathways, selected platelet-rich-plasma pathways with a careful framing of evidence, and selected adjunct contexts). The recommendation arrives at the consultation through the suitability framework rather than as a pre-decided pathway.

For most pattern hair-thinning cases, medical management — calibrated topical and oral pharmacology — is the foundation pathway, with procedural adjuncts where the case warrants them. The framework treats the medical foundation as substantive rather than as the warm-up to a procedural pathway, and patients on the medical pathway alone often receive the calibrated outcome they were seeking without procedural escalation.

PRP pathway evidence in hair-fall is calibrated rather than absolute — selected case profiles show useful response, others show limited additional benefit beyond the medical foundation. The framework discusses where PRP fits and where it does not at the consultation, with realistic outcome framing rather than promotional claims. It is not positioned as a fixed-outcome lifetime pathway.

Surgical hair-restoration pathways (transplantation) sit outside the in-clinic procedural range at Delhi Derma Clinic; the consultation can discuss the framework around when surgical pathways become an appropriate consideration and refer the patient appropriately. The framework treats referral as part of patient-care continuity rather than as competition.

Laser-hair-reduction calibration is by skin-and-hair contrast, area, and patient-skin-context. Indian-skin Fitzpatrick III–VI calibration shapes parameter selection. Multi-session series are typical with sessions calibrated to the hair-cycle pattern across the treated zone. Realistic outcomes are framed as a calibrated reduction across the treated area with maintenance touch-points rather than as absolute lifetime hair-removal. The laser hair reduction page and LHR cost comparison page cover the framing.

The hair-pathway written plan covers the calibrated recommendation, the rationale, the realistic outcome trajectory across an evidence-based time window, the maintenance pattern (often substantial in hair pathways), the residual-risk profile, the per-component pricing for the recommended pathway, the proposed follow-up cadence, and any blood-work routing. The plan is the patient's document leaving the visit; the patient decides whether and when any next step happens.

Realistic outcomes for hair-fall pathways are framed as a graded trajectory rather than a fixed-outcome reset. For pattern hair-thinning, calibrated medical management often slows or stabilises the trajectory and supports selected regrowth; for telogen effluvium, the active-shedding window typically resolves with the underlying trigger and a return-to-baseline density follows over months. The framework states this honestly rather than promising rapid full regrowth.

Hair-pathway response operates on a slow biological clock. Useful early indicators emerge across three-to-six months for medical pathways; sustained outcomes are evaluated across twelve months and beyond. The framework calibrates expectations to this timeline rather than to a compressed timeframe, and follow-up reviews are scheduled accordingly.

No. The framework is explicit that calibrated laser-hair-reduction produces a substantial reduction in active hair growth across the treated area with structured maintenance touch-points; it does not produce absolute lifetime removal of every follicle on the treated zone. Selected hormonal-axis contexts and selected pattern-specific contexts can stimulate regrowth that warrants maintenance sessions. The framing is honest reduction-with-maintenance rather than absolute removal.

Hair-fall pathways have their own residual-risk profile — selected pharmacology has known side-effect patterns that are discussed transparently at the consent stage; selected procedural pathways have their own residual-risk profile around scalp irritation, transient response patterns, and selected unusual responses. Residual-risk discussion within hair pathways is treated as substantive content rather than as legal-defensive boilerplate.

Hair-pathway follow-up cadence is typically three-to-six months across the active phase, with longer-interval review thereafter. The slow biological response window in hair pathways means that frequent short-interval review is generally not informative. Photographic baseline-versus-current comparison is typically part of the follow-up.

For hair pathways, structured photographic baseline at the start and at follow-up touch-points is particularly useful because human visual memory drifts over months and the patient often under-perceives gradual trajectory change. The framework treats photographic tracking as supportive of accurate progress assessment. Patient consent and confidentiality framework apply.

Selected hair-pathway follow-up reviews — particularly medical-pathway continuity reviews where new hands-on examination is not necessary — are appropriate for video format. Initial assessment and decisions that depend on hands-on scalp examination are routed in-person. The Teleconsultation Policy in the policies section is the formal source.

The follow-up review is the touch-point for revision conversation. Where the pathway is not tracking the expected response, the framework adjusts — escalation to additional pathway elements, change of approach where the early-response data warrants it, or referral where the case warrants specialty input. The framework does not hold the patient to the original plan as a sunk-cost commitment.

Hair-pathway records — including baseline and follow-up photography — are held under the Patient Privacy and Records Policy framework as confidential, access-controlled material. Hair-pathway records are accessible only to the dermatologist and the trained clinical-team members operating in the patient's care. The privacy policy in the policies section is the formal source for the binding mechanics.